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Background:  Ceramide-1-phosphate  (C1P)  is  a  phosphorylated  form  of ceramide.  While  ceramide  is
known  to be an  inducer  of  apoptosis  of  cochlear  hair  cells  in cisplatin  ototoxicity,  little  is known  about
the  function  of  C1P  in  cochlear  diseases.
Purpose:  The  present  study was  designed  to  examine  whether  C1P could  protect  cochlear  hair  cells  against
cisplatin  ototoxicity.
Materials and  methods:  Explants  of  cochlear  basal  turns  collected  from  C57BL/6J  mice  at  postnatal  days  3–5
were used  in  all  experiments.  Cochlear  explants  were  exposed  to 5  or 10 M cisplatin  for  48  h to  assess
the  effects  of C1P,  NVP-231  (a ceramide  kinase  inhibitor),  or ceramide.  Western  blotting  of  pAkt/Akt  and
pMAPK/MAPK  was  examined  to check  whether  this  pathway  was  modulated  by C1P.
Results:  C1P  activated  the  Akt  and  MAPK  pathway  and  signiﬁcantly  reduced  cochlear  cell  death  induced
by cisplatin.  Coadministration  of  cisplatin  and  ceramide  signiﬁcantly  increased  cochlear  hair  cell  death.
In addition,  when  treating  cochlear  hair  cells  with  NVP-231  in the  presence  of  cisplatin  or ceramide,  a
remarkable  increase  in  apoptosis  of hair  cells  was  observed.
Conclusion:  The  present  ﬁndings  conﬁrmed  the  protective  effects  of  C1P  in  the cisplatin  ototoxicity.  The
balance  between  ceramide  and  C1P  may  play  a critical  role in the determination  of hair  cell  fate  in cisplatin
ototoxicity.
© 2016  Published  by  Elsevier  Ireland  Ltd.  This is an  open  access  article  under the CC  BY-NC-ND. Introduction
Cochlear hair cells have a crucial function to convert sound sig-
als to electric signals in the auditory system; however, they are
ery sensitive to harmful stimulations such as cisplatin used in
hemotherapy.
Ceramide is generally formed either via de novo synthesis from
erine and palmitoyl-CoA or via hydrolysis of sphingomyeline by
phingomyelinase [1,17]. It was demonstrated that cisplatin acti-
ates sphingomyelinase, which triggers the release of ceramide
18]. Although ceramide is known to be an inducer of apoptosis
n aminoglycoside ototoxicity [19], the effects of ceramides on cis-
latin ototoxicity have never been examined.
Ceramide-1-phosphate (C1P) is synthesized by phosphorylation
f ceramide in mammalian cells [6]. Currently, ceramide kinase
∗ Corresponding author at: Department of Otolaryngology, Faculty of Medicine,
niversity of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Japan.
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214-7500/© 2016 Published by Elsevier Ireland Ltd. This is an open access article under license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(CERK) is the only known mammalian enzyme to have this function.
Since the ﬁrst biological activity of C1P relating to DNA synthesis
and cell division was  identiﬁed [10,11], researchers have found that
this phospholipid was  attributed to various vital functions, such as
macrophage proliferation and migration [7,14], phagocytosis [15],
inﬂammation [22,23] and cell protection [12,13]. However, it has
not been revealed yet whether C1P could inhibit cisplatin-induced
cochlear hair cell death.
Induction of cell death is a complex process and tightly reg-
ulated. In the present study we hypothesized that C1P could be
an antiapoptotic molecule and that targeted ceramide/C1P balance
could interfere cochlear cell survival.
2. Methods
2.1. Culture technique2.1.1. Cochlear explants
The lower basal turn of the organ of Corti was  dissected from
C57BL/6J mouse on postnatal days 3 (P3) to 5 (P5) and cultured
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Effects of C1P on the survival of cochlear outer hair cell in cisplatin ototoxicity. (A) Quantitative analysis of cochlear outer hair cells. The survival of cochlear outer
hair  cells signiﬁcantly increased at 10 M C1P or higher (ANOVA followed by Bonferroni post hoc test, *P < 0.05). (B − G) Representative photographs of each group (scale bar
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o0  m).  (B) 100 M C1P alone. (C) 10 M cisplatin alone. (D) 10 M cisplatin and
0  M cisplatin and 100 M C1P. CDDP: cisplatin.
ccording to the methods of Van de Water and Ruben [29] and
obkowicz et al. [25]. All animal procedures were carried out
ccording to the guidelines of the Laboratory Animal Research Cen-
er of Tsukuba University.
.1.2. Cisplatin treatment
Cochlear explants were maintained in a culture medium con-
aining Dul-becco’s modiﬁed Eagle’s medium (DMEM), 10% fetal
ovine serum (FBS), 25 mM HEPES, and 30 U/mL penicillin. They
ere cultured in an incubator at 37 ◦C with 5% CO2 at 95% humid-
ty. Cochlear explants were maintained in the culture medium
vernight (8–12 h) and then were exposed to the culture medium
ontaining cisplatin (Nichi-Iko, Sogawa, Japan) for 48 h [27].Cisplatin-induced ototoxicity was characterized by the missing
f cochlear outer hair cells at the basal turn of the organ of Corti.
efore conducting this study, we examined the damage of cochlear
uter hair cells by exposing cochlear explants to several concentra- C1P. (E) 10 M cisplatin and 10 M C1P. (F) 10 M cisplatin and 30 M C1P. (G)
tions of cisplatin from 1 to 50 M.  The concentrations of cisplatin
at 5 and 10 M were chosen for the present experiments.
2.1.3. C1P treatment
C1P (Sigma, St. Louis, MO,  USA) was initially dissolved in ethanol
at a concentration of 2 mg/ml, and then diluted in the culture
medium to the ﬁnal concentrations before use. After the cochlear
explants were stabilized in the culture medium overnight, each
group (from 9 to 18 cochlear explants) was  exposed to culture
media containing 10 M cisplatin plus various concentrations of
C1P (from 1 to 100 M)  for 48 h.
2.1.4. Ceramide treatment
C16-ceramide (LKT Laboratories, St. Paul, MN,  USA) was  dis-solved in ethanol at a concentration of 5 mg/ml. The effect of
ceramide alone on cochlear explants was  tested using concentra-
tions from 10 to 500 M.  Later, the combination of 5 M cisplatin
and various concentrations of ceramide (from 10 to 500 M)  was
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Fig. 2. Representative Western blots of pAkt, total Akt, pMAPK and total MAPK. Comparisons were conducted among 3 groups: control group (no cisplatin), 10 M cisplatin
plus  100 M C1P group, and 10 M cisplatin group. (A) Chemiluminescent detection of pAkt and Akt with 24-h treating time. (C) Chemiluminescent detection of pAkt and
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nd  pMAPK in comparison to groups without C1P (t-Test, P < 0.05). Densitometric v
o  total Akt and total MAPK, respectively. Data were obtained from three independ
xamined. In another condition, 500 M ceramide was selected to
ix  with various concentrations of NVP-231 (from 10 to 200 M),
nd this combination was applied to assess the survival of cochlear
uter hair cells. In all experiments, cochlear explants were stabi-
ized in the normal culture medium overnight before treated in
ifferent conditions for 48 h.
.1.5. NVP-231 treatment
NVP-231 was dissolved in dimethyl sulfoxide (DMSO) (Sigma,
t. Louis, MO,  USA) at a concentration of 10 mg/ml. After being sta-
ilized in the culture medium overnight, cochlear explants were
xposed to culture media containing 5 M cisplatin plus various
oncentrations of NVP-231 (from 0.1 to 10 M)  for 48 h. Using the
imilar experimental model as above, cochlear outer hair cells were
reated in culture media with 500 M ceramide plus NVP-231 rang-
ng from 10 to 200 M.8-h treating time. (B, D, F) C1P signiﬁcantly increased densitometric signals of pAkt
ere normalized to values of control group. pAkt and pMAPK have been referenced
periments. CDDP: cisplatin.
2.2. Cytochemistry
At the end of the tissue culture, cochlear explants were ﬁxed
with 4% paraformaldehyde in phosphate-buffered saline (PBS) for
20 min  and then permeabilized with 5% Triton X-100 (Sigma, St.
Louis, MO,USA) in PBS with 10% fetal bovine serum for 10 min. The
specimens were stained with phalloidin using a conjugated Alexa
Fluor probe (1:100, Molecular Probes, Carlsbad, CA, USA) at room
temperature for 1 h [27]. Phalloidin is a speciﬁc marker for cellu-
lar F-actin and labels stereociliary arrays and the cuticular plates
of hair cells. The specimens were observed using a confocal micro-
scope (FluoView F10i, Olympus, Center Valley, PA, USA). Hair cells
were characterized as missing if no stereocilia or no cuticular plates
were observed by phalloidin staining. Residue of cochlear outer
hair cells was  expressed as a percentage and the results of each the
groups were compared [27].
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aig. 3. Effects of ceramide on cochlear hair cell. (A) Quantitative analysis of cochle
ower  than 200 M and few were lost at 500 M. (B − F) Representative photograp
eramide. (E) 200 M ceramide. (F) 500 M ceramide. Cer: ceramide.
.3. Western blots
The organs of Corti were treated in culture media alone or in
ulture media containing either 10 M cisplatin or 10 M cisplatin
lus 100 M C1P for 24 or 48 h. Explants were then homoge-
ized in Pro-Prep protein extraction solution (iNtRON, Kyungki,
orea) following the product’s protocol. After being centrifuged at
3.000 rpm at 4 ◦C for 10 min, the supernatant was  transferred to
 fresh tube and the protein content was measured by using pro-
ein assay rapid kit (Wako, Osaka, Japan). Equal amounts of lysate
rotein (20 g) were electrophoretically separated on 4–20% mini-
ROTEAN TGX precast polyacrylamide gel (Bio-Rad, Hercules, CA,
SA) and transferred to Hybond polyvinylidene diﬂuoride mem-
rane (GE Healthcare, Buckinghamshire, UK). After blocking, each
embrane was primarily treated with polyclonal antibodies Akt
1:500), pAkt (1:500), MAPK (1:500), or pMAPK (1:500) overnight
t 4 ◦C. Horseradish peroxidase-conjugated goat anti-rabbit IgGer hair cells. All cochlear outer hair cells were intact with ceramide concentration
ach group (scale bar 20 m).  (B) 10 M ceramide. (C) 30 M ceramide. (D) 100 M
antibody (1:2000) was  secondarily treated for 1 h at room tem-
perature. The antibodies described above were purchased from
Cell Signaling Technology (Beverly, MA,  USA). Chemiluminescent
detection was enhanced with ECL kit (GE Healthcare, Bucking-
hamshire, UK) and the immunoblot images were obtained with
the ImageQuant LAS4000 mini imager (GE Healthcare, Bucking-
hamshire, UK). Densitometric analysis was done from at least 3
independent experiments by using ImageJ software (Nation Insti-
tutes of Health).
2.4. Data analysisAll data were expressed as the means ± SDs. Statistical analysis
was performed by t-test or one-way analysis of variance (ANOVA)
followed by Bonferroni post hoc tests, as required (SPSS 20). Prob-
ability values less than 0.05 were considered signiﬁcant.
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Fig. 4. Effects of ceramide on cisplatin-induced cochlear hair cell death. (A) Quantitative analysis of cochlear outer hair cells. The residue of cochlear outer hair cells decreased
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isplatin alone. (C) 5 M cisplatin and 10 M ceramide. (D) 5 M cisplatin and 100
eramide. CDDP: cisplatin.
. Results
.1. Control study
The effects of 100 M C1P, 10 M NVP-231 or solvents alone (1%
thanol and 0.04% DMSO) on cochlear hair cells were examined.
fter 48-h exposure to above agents, all of cochlear outer hair cells
emained intact. In addition, the interactions between cisplatin and
olvents were also checked. There were no signiﬁcant differences
n cochlear hair cell loss between explants treated with cisplatin
lone and one treated with cisplatin plus either 1% ethanol or 0.04%
MSO; the tested concentrations of cisplatin were 5 and 10 M
data not shown)..2. C1P and the survival of outer hair cell in cisplatin ototoxicity
We  examined the effect of C1P on cisplatin-induced outer hair
ell damage. The results revealed a dose-dependent relationship1). (B − F) Representative photographs of each group (scale bar 20 m). (B) 5 M
eramide. (E) 5 M cisplatin and 200 M ceramide. (F) 5 M cisplatin and 500 M
between C1P treatment and the survival of cochlear outer hair cells.
When compared with cisplatin treatment alone, the addition of C1P
treatment signiﬁcantly increased the survival of cochlear outer hair
cells at 10 M C1P or higher (Fig. 1; ANOVA followed by Bonfer-
roni post hoc test; 10 M-C1P group, n = 16, P = 0.014; 30 M-C1P,
n = 18, P = 0.03; 100 M-C1P, n = 9, P = 0.007; n is the number of
cochlear explants).
3.3. C1P and phosphorylation of akt and MAPK
The above results suggested that C1P could inhibit cochlear
outer hair cell death induced by cisplatin. Next, Western blots
were conducted to determine whether this effect of C1P involves
the stimulation of the PI3-K/Akt or ERK/MAPK pathway. Cochlear
explants were treated in 3 different conditions, including the
culture medium alone, 10 M cisplatin, or 10 M cisplatin plus
100 M C1P. Immunoblot images revealed strong activations of
Akt (Fig. 2A and C) and MAPK (Fig. 2E) in cochlear explants treated
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Fig. 5. Effects of NVP-231 on cisplatin-induced cochlear hair cell death. (A) Quantitative analysis of cochlear outer hair cells. The survival of cochlear outer hair cells was
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roup  (scale bar 20 m).  (B) 10 M NVP-231 alone. (C) 5 M cisplatin alone. (D) 5 
nd  10 M NVP-231. CDDP: cisplatin.
ith C1P. In addition, densitometric analysis also revealed signif-
cant increases of pAkt in a group of C1P addition compared to
 group without C1P for 24 h (Fig. 2B; t-Test, P = 0.005) or 48 h
Fig. 2D; t-Test, P = 0.025). The signal of pMAPK was also signif-
cantly increased when C1P was added for 48 h (Fig. 2F; t-Test,
 = 0.015)
.4. The effect of ceramide on cisplatin-induced cochlear hair cell
eath
Ceramide is a regulator of cellular apoptosis, and this experi-
ent was conducted to show whether or not ceramide ampliﬁes
isplatin-induced hair cell death. First, ceramide alone was exam-
ned on cochlear explants. All cochlear outer hair cells were intact
t 200 M ceramide or lower, and very few hair cells were lost at
00 M (Fig. 3.). Later, several concentrations of ceramide as above
ere tested with 5 M cisplatin addition. Only the condition of
00 M ceramide plus 5 M cisplatin signiﬁcantly decreased the
umber of cochlear outer hair cells (Fig. 4; ANOVA followed by
onferroni post hoc test; n = 9, P < 0.001 at 500 M).y Bonferroni post hoc test, *P < 0.05). (B − F) Representative photographs of each
platin and 1 M NVP-231. (E) 5 M cisplatin and 3 M NVP-231. (F) 5 M cisplatin
3.5. CERK inhibitor and cochlear hair cell death induced by
cisplatin or ceramide
CERK converts ceramide to C1P and contributes to the balance
of the C1P and ceramide levels. NVP-231, a selective CERK inhibitor,
was used to evaluate the involvement of CERK when cochlear outer
hair cells exposure to cisplatin or ceramide. At ﬁrst, 5 M cisplatin
was mixed with to several concentrations of NVP-231. Outer hair
cell death induced by 5 M cisplatin was signiﬁcantly exacerbated
in the presence of NVP-231 at 3 M or higher (Fig. 5; ANOVA fol-
lowed by Bonferroni post hoc test; 3 M NVP-231 group, n = 10,
P = 0.008; 10 M NVP-231 group, n = 10, P = 0.005). Later, in a dif-
ferent condition, 500 M ceramide was combined with several
concentrations of NVP-231. Outer hair cell death was severely dam-
aged, starting with 10 M NVP-231, and hair cells were completely
unable to identify at 200 M (Fig. 6; ANOVA followed by Bonferroni
post hoc test; 10 M NVP-231 group, n = 9, P = 0.000; 30 M NVP-
231 group, n = 10, P = 0.000; 100 M NVP-231 group, n = 9, P = 0.000)
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Fig. 6. Effects of NVP-231 on cochlear hair cell treated with ceramide. (A) Quantitative analysis of cochlear outer hair cells. The survival of cochlear outer hair cells was
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. Discussion
It has been demonstrated that C1P participates in several vital
athophysiological functions including regulation of cell growth
nd survival, stimulation of DNA synthesis and cell division, and
nhibition of cellular apoptosis [3,9,11]. In the present study, its
nvolvement in cisplatin-induced hair cell death was  investigated.
y using C1P, cisplatin-induced cochlear outer hair cell death was
uccessfully suppressed in our experiments.
In the ﬁrst few hours of cisplatin exposure, cochlear hair cells
nhance their defence mechanisms by inducing the upregulation
f several anti-apoptotic genes that are associated with the NF-
B pathway, caspase recruitment domain family, IAP family, Bcl-2
amily, and p53 signaling [5]. These signaling pathways are alsomedia containing 500 M ceramide (ANOVA followed by Bonferroni post hoc test,
 ceramide alone. (C) 500 M ceramide and 10 M NVP-231. (D) 500 M ceramide
d 200 M NVP-231; all explants were severely damaged. Cer: ceramide.
known to be stimulated by the PI3-K/Akt pathway. Our study
revealed that activation of the PI3-K/Akt pathway was at least one
of the mechanisms in which C1P promotes cochlear hair cell sur-
vival. Besides, the activity of sphingomyelinase, which converts
sphingomyeline to ceramide, was reportedly restrained by the acti-
vation of this pathway [28] and as a result prevented the increase
of ceramide [20]. Additionally, the activation of MAPK/ERK path-
way, which is related to cell growth, could be another explanation
of cochlear hair cell survival in our study. In fact, this activation was
reported in experimental models of C1P with osteoblastic cells [3]
and macrophages [8].Ceramide causes the death of neuronal cells in the central and
peripheral nervous systems [2,4,30]. Although its precise mecha-
nism remains unclear, it is currently thought that ceramide induces
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[Q. Le et al. / Toxicology
ellular apoptosis via activation of multiple pathways (e.g., PKC,
P2A, etc.) [24]. Ceramide reportedly inhibits the PI3-K/Akt path-
ay [31]. In the present study, ceramide alone had least effects
n cochlear hair cells. Co-administration of ceramide and cisplatin
nly accelerated the death of cochlear outer hair cells at very
igh concentration. In mammalian cells, CERK directly phosphory-
ates ceramide to synthesize C1P and is currently the only known
nzyme to have this function [26]. Therefore, we  hypothesized that
ochlear hair cells might have a high intrinsic activity of CERK,
hich rapidly phosphorylates ceramide resulting in increase of C1P
ynthesis; thus, cochlear hair cells were protected from the dam-
ge of high ceramide concentration. When treating cochlear hair
ells with NVP-231 (a CERK inhibitor) in the presence of cisplatin
r ceramide, we observed remarkable increases of apoptosis. These
esults conﬁrmed our hypothesis above and explained partly the
entral role of C1P in governing cochlear hair cell fate.
Taken together our results suggest the importance of the bal-
nce between ceramide and C1P. On one hand, ceramides triggers
poptosis via several pathways including blocking the PI3-K/Akt;
n the other hand, C1P inhibits this process by activating the PI3-
/Akt pathway and increase phosphorylation of MAPK. In short, our
resent study suggests that at least the balance of ceramide and
1P regulates cochlear hair cell fate, and any circumstances that
lter this balance (e.g., a CERK inhibitor) will affect the survival of
ochlear hair cell.
Since the discovery of CERK over 10 years ago, some evidences
howed that inhibition of CERK might enhance the efﬁcacy of anti-
ancer therapies. When the activity of CERK is abolished, it greatly
ncreases the susceptibility of tumor cell lines to low-dose UV irra-
iation [16]. Furthermore, it is suggested that the inhibition of CERK
ill overcome the issue of chemotherapeutic resistance by rising
eramide levels in combination of chemotherapies [21]. However,
he inhibition of CERK needs to be approached with great caution,
ecause of a possibility of an unbalance between ceramide and C1P.
he elevation of ceramide level would possibly render other nor-
al  cells more vulnerable to the treatment − particularly cochlear
air cells in cisplatin ototoxicity, as the ﬁndings of our study.
In summary, this present study provides evidences that C1P reg-
lates cochlear hair cell survival in cisplatin ototoxicity through the
I3-K/Akt and MAPK pathway.
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